Pillar Pacific Capital Management LLC Boosts Position in Roche Holding AG (OTCMKTS:RHHBY)

Pillar Pacific Capital Management LLC grew its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 0.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 167,648 shares of the company’s stock after acquiring an additional 1,419 shares during the quarter. Pillar Pacific Capital Management LLC’s holdings in Roche were worth $7,325,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Harding Loevner LP acquired a new stake in shares of Roche in the third quarter valued at about $260,611,000. Fisher Asset Management LLC grew its stake in shares of Roche by 3,477.8% in the fourth quarter. Fisher Asset Management LLC now owns 448,975 shares of the company’s stock valued at $19,618,000 after buying an additional 436,426 shares in the last quarter. Douglass Winthrop Advisors LLC grew its stake in Roche by 20.7% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 1,028,987 shares of the company’s stock valued at $44,051,000 after purchasing an additional 176,751 shares in the last quarter. Williams Jones Wealth Management LLC. grew its stake in Roche by 22.6% during the 3rd quarter. Williams Jones Wealth Management LLC. now owns 413,796 shares of the company’s stock valued at $17,715,000 after purchasing an additional 76,173 shares in the last quarter. Finally, Bowen Hanes & Co. Inc. grew its stake in Roche by 2.7% during the 3rd quarter. Bowen Hanes & Co. Inc. now owns 1,042,070 shares of the company’s stock valued at $44,611,000 after purchasing an additional 27,340 shares in the last quarter. Institutional investors own 0.32% of the company’s stock.

Shares of Roche stock traded down $0.16 on Tuesday, hitting $42.01. 1,674,702 shares of the company’s stock traded hands, compared to its average volume of 2,362,335. The firm’s 50-day moving average price is $43.75 and its two-hundred day moving average price is $43.30. The stock has a market capitalization of $287.71 billion, a PE ratio of 16.54, a price-to-earnings-growth ratio of 3.69 and a beta of 0.35. Roche Holding AG has a one year low of $35.04 and a one year high of $47.15. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.23 and a quick ratio of 0.93.

Several analysts recently issued reports on RHHBY shares. Barclays reissued an “overweight” rating on shares of Roche in a report on Friday, January 22nd. Deutsche Bank Aktiengesellschaft started coverage on Roche in a research report on Friday, January 15th. They issued a “hold” rating on the stock. Oddo Bhf cut Roche from a “reduce” rating to an “underperform” rating in a research report on Thursday, February 4th. UBS Group cut Roche from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 17th. Finally, JPMorgan Chase & Co. restated a “neutral” rating on shares of Roche in a research report on Wednesday, February 10th. Two analysts have rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $48.00.

About Roche

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation.

Featured Article: QQQ ETF

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.